Hydatidiform Mole, Recurrent, 1; Hydm1
Description
A hydatidiform mole is an abnormal pregnancy characterized by hydropic placental villi, trophoblastic hyperplasia, and poor fetal development. Familial recurrent hydatidiform mole is an autosomal recessive condition in which women experience recurrent pregnancy losses, predominantly complete hydatidiform mole (CHM). However, unlike sporadic CHMs, which are androgenetic with 2 paternal chromosome complements, CHMs associated with familial recurrence are genetically biparental in origin with both a maternal and a paternal contribution to the genome. Other pregnancy losses in this condition include partial hydatidiform mole, stillbirths, ectopic pregnancies, early neonatal deaths, and miscarriages, some of which may be undiagnosed molar pregnancies. Normal pregnancies are extremely rare in families with this condition (summary by Fallahian et al., 2013).
Clinical Features
Phenotypes and symptoms related to Hydatidiform Mole, Recurrent, 1; Hydm1
- Neoplasm
- Nevus
- Abnormality of the genitourinary system
- Choriocarcinoma
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Hydatidiform Mole, Recurrent, 1; Hydm1 Is also known as hydatidiform mole, complete, gestational trophoblastic disease, hydatidiform mole, chm, hydm.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Hydatidiform Mole, Recurrent, 1; Hydm1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
NLRP7.
By Institute for Human Genetics University Clinic Freiburg (Germany).
NLRP7
Specificity
100 %
Genes
100 % |
NLRP7. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
NLRP7
Specificity
100 %
Genes
100 % |
Hydatidiform Mole (sequence analysis of NLRP7 gene).
By CGC Genetics (Portugal).
NLRP7
Specificity
100 %
Genes
100 % |
Autoinflammatory panel.
By Genome Diagnostics Laboratory University Medical Center Utrecht (Netherlands).
SH3BP2, TNFRSF1A, LPIN2, IL36RN, NLRP3, NCSTN, NLRP12, NLRP7, PSENEN, NOD2, IL10, IL10RA, IL10RB, IL1RN, MEFV, MVK, PLCG2, PSMB8, PSTPIP1
Specificity
6 %
Genes
100 % |
Hydatidiform mole.
By Centogene AG - the Rare Disease Company (Germany).
NLRP7
Specificity
100 %
Genes
100 % |
Pan-Ethnic Carrier Screen: Gene Sequencing Panel.
By EGL Genetic Diagnostics Eurofins Clinical Diagnostics (United States).
RMRP, BCS1L, RS1, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC19A2, SLC22A5, SLC26A2, SMN1, SMPD1, BTD, TH, TTPA, TYR , (...)
View the complete list with 127 more genes
Specificity
1 %
Genes
100 % |
NLRP7.
By Fulgent Genetics Fulgent Genetics (United States).
NLRP7
Specificity
100 %
Genes
100 % |
Hydatidiform mole.
By Bioarray (Spain).
NLRP7
Specificity
100 %
Genes
100 % |
You can get up to 3 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3 RENPENNING SYNDROME 1; RENS1 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A COFFIN-SIRIS SYNDROME 6; CSS6 SHWACHMAN-DIAMOND SYNDROME; SDS SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION